{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T20:53:56Z","timestamp":1760043236301,"version":"3.33.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.ejphar.2007.07.053","type":"journal-article","created":{"date-parts":[[2007,8,4]],"date-time":"2007-08-04T11:11:35Z","timestamp":1186225895000},"page":"107-113","source":"Crossref","is-referenced-by-count":6,"title":["Effects of kappa opioid agonists alone and in combination with cocaine on heart rate and blood pressure in conscious squirrel monkeys"],"prefix":"10.1016","volume":"576","author":[{"given":"Charles W.","family":"Schindler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zofi","family":"Graczyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne P.","family":"Gilman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Stevens","family":"Negus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy K.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven R.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2007.07.053_bib1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/BF02532378","article-title":"Cyclazocine revisited","volume":"21","author":"Archer","year":"1996","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2007.07.053_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1476-5381.1994.tb14815.x","article-title":"Central and peripheral actions of the novel \u0138-opioid receptor agonist, EMD 60400","volume":"111","author":"Barber","year":"1994","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib3","first-page":"232","article-title":"Systemic and regional hemodynamic and biological efects of a new kappa-opioid agonists, niravoline, in healthy volunteers","volume":"278","author":"Bellissant","year":"1996","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.07.053_bib4","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.bjp.0706782","article-title":"Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex","volume":"148","author":"Berger","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/sj.npp.1300105","article-title":"Effects of mixed-action kappa\/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys","volume":"28","author":"Bowen","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2007.07.053_bib6","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0022-3565(24)29530-6","article-title":"Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists","volume":"297","author":"Carey","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2007.07.053_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00496099","article-title":"Ethylketocyclazocine decreases noradrenaline release and blood pressure in the rabbit at a peripheral opioid receptor","volume":"328","author":"Ensinger","year":"1984","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0014-2999(85)90766-6","article-title":"Central and peripheral sites for cardiovascular actions of dynorphin-(1\u201313) in rats","volume":"111","author":"Gautret","year":"1985","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib9","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1901\/jeab.1963.6-297","article-title":"An apparatus for delivering pain shock to monkeys","volume":"6","author":"Hake","year":"1953","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.ejphar.2007.07.053_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0196-9781(83)90007-4","article-title":"Differential cardiovascular effects mediated by mu and kappa opiate receptors in hindbrain nuclei","volume":"4","author":"Hassen","year":"1983","journal-title":"Peptides"},{"key":"10.1016\/j.ejphar.2007.07.053_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1152\/ajplegacy.1969.217.1.24","article-title":"Arterial hypertension in the squirrel monkey during behavioral experiments","volume":"217","author":"Herd","year":"1969","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/y98-017","article-title":"Opioid reward mechanisms: a key role in drug abuse?","volume":"76","author":"Herz","year":"1998","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.ejphar.2007.07.053_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1476-5381.1990.tb12110.x","article-title":"CI-977, a novel and selective agonist for the k-opioid receptor","volume":"101","author":"Hunter","year":"1990","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1517\/13543776.14.12.1725","article-title":"Kappa-opioid receptor ligands","volume":"14","author":"Husbands","year":"2004","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejphar.2007.07.053_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1139\/y86-123","article-title":"Neurogenic dilatation and constriction of rat superior mesenteric artery in vitro: mechanisms and mediators","volume":"64","author":"Kannan","year":"1986","journal-title":"Can. J. Physiol. Pharm."},{"key":"10.1016\/j.ejphar.2007.07.053_bib16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0006-291X(85)80134-0","article-title":"Opiate binding in rat hearts: modulation of binding after hemorrhagic shock","volume":"127","author":"Krumins","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2007.07.053_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(83)90547-2","article-title":"Central cardiovascular effects of \u0138 agonists dynorphin-(1-13) and ethylketocyclazonine in the anesthetized rat","volume":"96","author":"Laurent","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib18","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0028-3908(82)90085-5","article-title":"Effects of ketazocine, ethylketaocine and phenazocine on schedule-controlled behavior: antagonism by naloxone","volume":"21","author":"Leander","year":"1982","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2007.07.053_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1124\/mol.61.1.73","article-title":"Molecular basis of differences in (\u2212)(trans)-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat kappa-opioid receptors expressed in Chinese hamster ovary cells","volume":"61","author":"Li","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1254\/jjp.45.125","article-title":"Positive inotrophic action of kappa opiate agonists, ethylketocyclazocine and dynorphin-A(1-13), in isolated rat atrium","volume":"45","author":"Maeda","year":"1987","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib21","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0166-2236(88)90093-8","article-title":"Anatomy of CNS opioid receptors","volume":"11","author":"Mansour","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejphar.2007.07.053_bib22","first-page":"283","article-title":"Pharmacology of opioids","volume":"35","author":"Martin","year":"1984","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2007.07.053_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1749-6632.2000.tb06678.x","article-title":"Interactions between kappa opioid agonists and cocaine: preclinical studies","volume":"909","author":"Mello","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2007.07.053_bib24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/sj.npp.1300631","article-title":"Effects of the mixed mu\/kappa opioid nalbuphine on cocaine-induced changes in subjective and cardiovascular responses in men","volume":"30","author":"Mello","year":"2005","journal-title":"Neuropsychopharmacology"},{"year":"2003","series-title":"Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research","author":"National Research Council","key":"10.1016\/j.ejphar.2007.07.053_bib25"},{"key":"10.1016\/j.ejphar.2007.07.053_bib26","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/00005344-198609000-00011","article-title":"Cardiovascular responses to medullary microinjections of opiate agonists in urethane-anesthetized rats","volume":"8","author":"Punnen","year":"1986","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib27","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/sj.bjp.0705763","article-title":"Peripheral kappa-opioid agonists for visceral pain","volume":"141","author":"Riviere","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0006-8993(91)91737-L","article-title":"Intrathecal administration of dynorphin A and its fragments increase heart rate and arterial pressure in the urethane anesthetized rat: mediation by a nonopioid mechanism","volume":"565","author":"Rochford","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2007.07.053_bib29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejphar.2003.11.078","article-title":"k-opioid receptors are differentially labeled by arylacetamides and benzomorphans","volume":"485","author":"Rusovici","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0002-9149(02)02622-X","article-title":"Influence of morphine sulfate on cocaine-induced coronary vasoconstriction","volume":"90","author":"Saland","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/1355621961000124676","article-title":"Cocaine and cardiovascular toxicity","volume":"1","author":"Schindler","year":"1996","journal-title":"Addict. Biol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0143-4179(83)90016-1","article-title":"Immunoreactive dynorphin in rat tissues and plasma","volume":"3","author":"Spampinato","year":"1983","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2007.07.053_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1006\/phrs.1993.1022","article-title":"Chlorisondamine, a non-competitive ganglionic blocker, antagonizes the cardiovascular effects of cocaine in conscious squirrel monkeys","volume":"27","author":"Tella","year":"1993","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2007.07.053_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0024-3205(93)90451-8","article-title":"The kappa-opioid receptor: Evidence for the different subtypes","volume":"52","author":"Wollermann","year":"1993","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2007.07.053_bib35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/0022-2828(90)90080-L","article-title":"Effects of drugs interacting with opioid receptors during normal perfusion or ischemia and reperfusion in the isolated rat heart \u2014 an attempt to identify cardiac opioid receptor subtypes(s) involved in arrhythmogenesis","volume":"22","author":"Wong","year":"1990","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ejphar.2007.07.053_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000109438","article-title":"Signal transduction in the cardiac k-receptor","volume":"4","author":"Wong","year":"1995","journal-title":"Biol. Signals"},{"key":"10.1016\/j.ejphar.2007.07.053_bib37","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/0278-5846(83)90028-3","article-title":"Some thoughts on the relations between animal and human drug-taking","volume":"7","author":"Woods","year":"1983","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejphar.2007.07.053_bib38","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0091-3057(89)90334-1","article-title":"Cardiovascular and respiratory effects of an opioid agonist ethylketazocine and sigma agonist N-allylnormetazocine in acutely decerebrated dogs","volume":"34","author":"Wu","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2007.07.053_bib39","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0091-3057(83)90349-0","article-title":"Self-administration of ketocyclazocine and ethylketocyclazocine by the rat","volume":"19","author":"Young","year":"1983","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907008436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299907008436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T04:00:49Z","timestamp":1737345649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299907008436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":39,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0014299907008436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2007.07.053","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}